Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr

This study has been terminated.

( due to multiple subjects reporting pain and burning at the phlebotomy sites after 38hr )

Study NCT00648414 Information provided by Mylan Pharmaceuticals

First Received: March 30, 2008 Last Updated: March 31, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	October 2006 (Final data collection date for primary outcome measure)